SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-19-043863
Filing Date
2019-09-09
Accepted
2019-09-09 08:00:17
Documents
2
Period of Report
2019-09-06

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv529005_3.html 3  
1 OWNERSHIP DOCUMENT tv529005_3.xml 3 1602
2 EXHIBIT 24.1 tv529005_ex24-1.htm EX-24.1 3434
  Complete submission text file 0001144204-19-043863.txt   6805
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Issuer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BRAINSTORM CELL THERAPEUTICS, INC. 1325 AVENUE OF AMERICAS, 28TH FLR. NEW YORK NY 10019
Business Address
Shah Preetam (Reporting) CIK: 0001787403 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36641 | Film No.: 191080998